Neem Oil Extract Induced Colorectal Cancer Cell Death
Researchers found that essential oil from Azadirachta indica leaves inhibited the growth of human colorectal cancer cells.
Updated on Sept. 24, 2026 in Cancer
A laboratory study has identified that essential oil extracted from Azadirachta indica leaves successfully induces apoptosis in HT-29 colorectal cancer cells. The findings suggest the treatment effectively inhibits cell proliferation through specific genetic pathways.
Why it matters
The study aims to establish whether botanical extracts can target oncoproteins associated with colorectal cancer survival and growth. By identifying specific gene targets, the research seeks to uncover new therapeutic mechanisms for cancer intervention.
Researchers observed apoptosis rates of 24.3 percent at 5 μg/mL and 41.8 percent at 10 μg/mL concentrations in HT-29 cells. Network pharmacology further identified 135 overlapping gene targets shared between the plant extract and colorectal cancer.
The players
HT-29
This is a well-known human colorectal adenocarcinoma cell line used extensively in cancer research to study drug efficacy.
Azadirachta indica
Commonly known as neem, this plant is frequently studied in pharmacology for its diverse range of bioactive phytochemical properties.
The details
Molecular analysis revealed that treatment with the essential oil increases expression levels of Caspase 3, Caspase 9, and Bax, while simultaneously decreasing BCL-2 expression. Molecular docking indicated that the compound phytol achieved the highest binding affinity against key oncoproteins such as STAT3 and NFKB1.
Timeline
24 hours was the duration of the incubation period for the HT-29 cancer cells treated with the essential oil.
Health Landscape
This study follows a testing pattern consistent with the NCI-60 human tumor cell line screening program by evaluating cytotoxic effects on specific cancer cell lines. It reflects the ongoing scientific effort to isolate botanical compounds that can disrupt oncogenic signaling pathways.
This research is in the early stages of laboratory discovery and does not yet offer direct changes to existing clinical treatment routines. Patients should continue to rely on established, evidence-based medical protocols rather than unverified plant-based treatments.
The takeaway
While the induction of apoptosis in a laboratory setting is a positive indicator, it does not confirm the efficacy of the substance for humans. Future research will need to determine if these results can be replicated in animal models or clinical settings.
Further reading
For more information on current laboratory research, visit the Cancer section.
Source note: This article includes information reported by Nature.
